RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 829.00
+29.00 (3.63%)
At close: Mar 27, 2026
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 21.57 billion as of March 27, 2026. Its market cap has increased by 137.97% in one year.
Market Cap
21.57B
Enterprise Value
21.22B
Revenue
3.98B
Ranking
n/a
PE Ratio
72.98
Stock Price
829.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has increased from 19.90B to 21.57B, an increase of 8.37%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 21.57B | -12.69% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 28.59B |
| Japan Tissue Engineering | 26.36B |
| Renascience | 24.19B |
| AnGes | 22.95B |
| StemRIM | 18.24B |
| ReproCELL | 16.66B |
| CanBas | 13.93B |
| Immuno-Biological Laboratories | 13.23B |